The financials
STERIS plc by the numbers
STERIS plc (STE) reported revenue of $1.59B in Q4 2026 (quarter ended March 31, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $220M (14% of revenue). For the full year FY2026, revenue was $5.94B (+8.7% year on year) and net income $782M. Its largest segment in 2025-Q4 was Healthcare at $1.06B, 71% of the disclosed total, just ahead of Applied Sterilization Technologies at 19%.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $1.59B | $1.48B | +7.3% |
| Gross profit | $697M | $641M | +8.7% |
| Operating income | $317M | $216M | +47% |
| Net income | $220M | $146M | +51% |
| Diluted EPS | $2.24 | $1.47 | +52% |
| Operating | Revenue | Share |
|---|---|---|
| Healthcare | $1.06B | 71% |
| Applied Sterilization Technologies | $287M | 19% |
| Life Science | $146M | 9.7% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q4 2025Total $1.50B (+2.5%)
Applied Sterilization Technologies grew +11% year on yearLife Science +6.9% year on year
Segment Latestquarter on quarteryear on year
- Healthcare$1.06B$1.06BQoQ -year on year +9.0%-+9.0%
- Applied Sterilization Technologies$286.6M$286.6MQoQ +1.8%year on year +11%+1.8%+11%
- Life Science$145.8M$145.8MQoQ +0.55%year on year +6.9%+0.55%+6.9%
- Healthcare--QoQ -year on year ---
- Healthcare--QoQ -year on year ---
- Life Science--QoQ -year on year ---
Medical Devices
Ranks #13 of 35 by Smart Score